Vanda Pharmaceuticals Inc. (VNDA)

NASDAQ: VNDA · Real-Time Price · USD

5.81

-0.16 (-2.60%)

At close: Jun 18, 2026, 4:00 PM EDT

5.82

+0.02 (0.26%)

After-hours: Jun 18, 2026, 7:46 PM EDT

Vanda Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	54.03	84.85	102.32	135.82	135.03	52.07
Short-Term Investments	148.28	179	272.33	252.44	331.83	380.74
Cash & Short-Term Investments	202.31	263.85	374.64	388.26	466.86	432.81
Cash Growth	-40.66%	-29.57%	-3.51%	-16.84%	7.87%	17.70%
Accounts Receivable	56.88	54.58	47.1	34.16	33.51	32.47
Inventory	1.7	1.85	1.73	1.36	1.19	1.03
Other Current Assets	32.28	26.99	15.42	9.17	17.73	12
Total Current Assets	293.17	347.26	438.89	432.95	519.29	478.3
Net Property, Plant & Equipment	14.07	13.51	12.68	9.14	10.97	12.39
Other Intangible Assets	115.1	117.09	114.1	121.37	18.57	20.08
Other Long-Term Assets	11.19	11.08	90.54	84.99	85.42	83.03
Total Assets	433.53	488.95	656.2	648.44	634.25	593.79
Accounts Payable	60.62	68.3	39.09	38.46	45.55	34.44
Other Current Liabilities	74.96	76.87	60.9	49.24	45.89	39.98
Total Current Liabilities	135.58	145.16	99.98	87.7	91.44	74.42
Long-Term Leases	7.05	7.07	8.09	7.01	8.81	10.06
Other Long-Term Liabilities	10.13	9.53	9.59	8.83	6.8	4.39
Total Long-Term Liabilities	17.18	16.6	17.68	15.83	15.61	14.45
Total Liabilities	152.76	161.76	117.66	103.53	107.05	88.86
Common Stock	0.06	0.06	0.06	0.06	0.06	0.06
Additional Paid-in Capital	723.83	721.26	712.71	700.27	686.24	669.22
Accumulated Other Comprehensive Income	0.21	0.63	0.07	-0.03	-1.19	-0.18
Retained Earnings	-443.33	-394.77	-174.29	-155.39	-157.9	-164.18
Shareholders' Equity	280.77	327.19	538.55	544.91	527.2	504.93
Total Liabilities & Equity	433.53	488.95	656.2	648.44	634.25	593.79
Total Debt	7.05	7.07	8.09	7.01	8.81	10.06
Net Cash (Debt)	195.26	256.78	366.55	381.26	458.05	422.76
Net Cash Growth	-23.96%	-29.95%	-3.86%	-16.76%	8.35%	18.67%
Net Cash Per Share	3.30	4.36	6.30	6.62	8.04	7.43
Book Value	280.77	327.19	538.55	544.91	527.2	504.93
Book Value Per Share	4.75	5.55	9.26	9.47	9.25	8.87
Tangible Book Value	165.66	210.1	424.45	423.54	508.63	484.85
Tangible Book Value Per Share	2.80	3.57	7.30	7.36	8.93	8.52

SEC Filings: 10-K · 10-Q